Alaunos Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $30.6M | $60.4M |
| FY2011 | — | $71.6M | $104.7M |
| FY2012 | — | $48.4M | $73.3M |
| FY2013 | — | $49.4M | $68.2M |
| FY2014 | — | $33.8M | $42.8M |
| FY2015 | — | $87.4M | $140.7M |
| FY2016 | — | $-77.3M | $81.1M |
| FY2017 | — | $-96.8M | $70.9M |
| FY2018 | — | $85.6M | $61.7M |
| FY2019 | — | $95.0M | $79.7M |